Characterization of the monoclonal antibody response to botulinum neurotoxin type A in the complexed and uncomplexed forms

Haiyang Zhao, Keiji Nakamura, Tomoko Kohda, Masafumi Mukamoto, Shunji Kozaki

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Clostridium botulinum produces large complex toxins, which include botulinum neurotoxin (BoNT) and auxiliary non-toxic proteins. We prepared monoclonal antibodies (mAbs) from mice that were immunized several times with BoNT/A after basal immunization with toxoid. We then examined the reactivities of these mAbs to BoNT and toxoid and showed that some mAbs reacted to only BoNT. This result indicates that the antigenicity of BoNT/A partially disappeared with formalin treatment. Some mAbs that specifically recognized either BoNT/A1 or BoNT/A2 were considered useful as detection antibodies specific for the BoNT/A subtype. Results of a neutralizing test with mAbs against either BoNT/A1 or BoNT/A2 showed that neutralizing antibody recognition sites were present in the light chain, heavy chain (N-terminal half), and heavy chain (C-terminal half) domains. Investigation of the different binding capabilities of the mAbs to BoNT and the complex toxin by immunoprecipitation suggested that the light chain of BoNT is exposed at the molecular surface of the complex toxin since there was no difference in the binding of light chain-specific mAb to BoNT and the complex toxin. The heavy chain is related to BoNT binding to non-toxic components, because the reactivity of the heavy chain to some mAbs was influenced by non-toxic components.

Original languageEnglish
Pages (from-to)138-145
Number of pages8
JournalJapanese Journal of Infectious Diseases
Volume65
Issue number2
Publication statusPublished - Apr 2 2012
Externally publishedYes

Fingerprint

Type A Botulinum Toxins
Neurotoxins
Antibody Formation
Monoclonal Antibodies
Toxoids
varespladib methyl
Light
Clostridium botulinum
Neutralizing Antibodies
Immunoprecipitation
Formaldehyde
Immunization

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Characterization of the monoclonal antibody response to botulinum neurotoxin type A in the complexed and uncomplexed forms. / Zhao, Haiyang; Nakamura, Keiji; Kohda, Tomoko; Mukamoto, Masafumi; Kozaki, Shunji.

In: Japanese Journal of Infectious Diseases, Vol. 65, No. 2, 02.04.2012, p. 138-145.

Research output: Contribution to journalArticle

@article{e92f12f5f9564a1fa2df8ef778d83ed1,
title = "Characterization of the monoclonal antibody response to botulinum neurotoxin type A in the complexed and uncomplexed forms",
abstract = "Clostridium botulinum produces large complex toxins, which include botulinum neurotoxin (BoNT) and auxiliary non-toxic proteins. We prepared monoclonal antibodies (mAbs) from mice that were immunized several times with BoNT/A after basal immunization with toxoid. We then examined the reactivities of these mAbs to BoNT and toxoid and showed that some mAbs reacted to only BoNT. This result indicates that the antigenicity of BoNT/A partially disappeared with formalin treatment. Some mAbs that specifically recognized either BoNT/A1 or BoNT/A2 were considered useful as detection antibodies specific for the BoNT/A subtype. Results of a neutralizing test with mAbs against either BoNT/A1 or BoNT/A2 showed that neutralizing antibody recognition sites were present in the light chain, heavy chain (N-terminal half), and heavy chain (C-terminal half) domains. Investigation of the different binding capabilities of the mAbs to BoNT and the complex toxin by immunoprecipitation suggested that the light chain of BoNT is exposed at the molecular surface of the complex toxin since there was no difference in the binding of light chain-specific mAb to BoNT and the complex toxin. The heavy chain is related to BoNT binding to non-toxic components, because the reactivity of the heavy chain to some mAbs was influenced by non-toxic components.",
author = "Haiyang Zhao and Keiji Nakamura and Tomoko Kohda and Masafumi Mukamoto and Shunji Kozaki",
year = "2012",
month = "4",
day = "2",
language = "English",
volume = "65",
pages = "138--145",
journal = "Japanese Journal of Infectious Diseases",
issn = "1344-6304",
publisher = "National Institute of Health",
number = "2",

}

TY - JOUR

T1 - Characterization of the monoclonal antibody response to botulinum neurotoxin type A in the complexed and uncomplexed forms

AU - Zhao, Haiyang

AU - Nakamura, Keiji

AU - Kohda, Tomoko

AU - Mukamoto, Masafumi

AU - Kozaki, Shunji

PY - 2012/4/2

Y1 - 2012/4/2

N2 - Clostridium botulinum produces large complex toxins, which include botulinum neurotoxin (BoNT) and auxiliary non-toxic proteins. We prepared monoclonal antibodies (mAbs) from mice that were immunized several times with BoNT/A after basal immunization with toxoid. We then examined the reactivities of these mAbs to BoNT and toxoid and showed that some mAbs reacted to only BoNT. This result indicates that the antigenicity of BoNT/A partially disappeared with formalin treatment. Some mAbs that specifically recognized either BoNT/A1 or BoNT/A2 were considered useful as detection antibodies specific for the BoNT/A subtype. Results of a neutralizing test with mAbs against either BoNT/A1 or BoNT/A2 showed that neutralizing antibody recognition sites were present in the light chain, heavy chain (N-terminal half), and heavy chain (C-terminal half) domains. Investigation of the different binding capabilities of the mAbs to BoNT and the complex toxin by immunoprecipitation suggested that the light chain of BoNT is exposed at the molecular surface of the complex toxin since there was no difference in the binding of light chain-specific mAb to BoNT and the complex toxin. The heavy chain is related to BoNT binding to non-toxic components, because the reactivity of the heavy chain to some mAbs was influenced by non-toxic components.

AB - Clostridium botulinum produces large complex toxins, which include botulinum neurotoxin (BoNT) and auxiliary non-toxic proteins. We prepared monoclonal antibodies (mAbs) from mice that were immunized several times with BoNT/A after basal immunization with toxoid. We then examined the reactivities of these mAbs to BoNT and toxoid and showed that some mAbs reacted to only BoNT. This result indicates that the antigenicity of BoNT/A partially disappeared with formalin treatment. Some mAbs that specifically recognized either BoNT/A1 or BoNT/A2 were considered useful as detection antibodies specific for the BoNT/A subtype. Results of a neutralizing test with mAbs against either BoNT/A1 or BoNT/A2 showed that neutralizing antibody recognition sites were present in the light chain, heavy chain (N-terminal half), and heavy chain (C-terminal half) domains. Investigation of the different binding capabilities of the mAbs to BoNT and the complex toxin by immunoprecipitation suggested that the light chain of BoNT is exposed at the molecular surface of the complex toxin since there was no difference in the binding of light chain-specific mAb to BoNT and the complex toxin. The heavy chain is related to BoNT binding to non-toxic components, because the reactivity of the heavy chain to some mAbs was influenced by non-toxic components.

UR - http://www.scopus.com/inward/record.url?scp=84859035770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859035770&partnerID=8YFLogxK

M3 - Article

C2 - 22446121

AN - SCOPUS:84859035770

VL - 65

SP - 138

EP - 145

JO - Japanese Journal of Infectious Diseases

JF - Japanese Journal of Infectious Diseases

SN - 1344-6304

IS - 2

ER -